Trial · NCT02265952
Results by group632
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 632
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) to Week 4 in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | -157.34 | Standard Deviation 89.590 | mg/dL | |
| Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) to Week 4 in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | -49.17 | Standard Deviation 23.136 | Percent Change | |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Week 2 to Week 4 in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | -63.63 | Standard Deviation 50.970 | Milligram per Deciliter (mg/dL) | |
| Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Week 2 to Week 4 in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | -30.05 | Standard Deviation 18.503 | Percent Change | |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Day 4 (n= 9) | -39.60 | Standard Deviation 41.677 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 1 (n= 9) | -67.59 | Standard Deviation 46.041 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 2 (n= 9) | -93.71 | Standard Deviation 86.504 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 3 (n= 9) | -129.97 | Standard Deviation 90.533 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 4 (n= 9) | -157.34 | Standard Deviation 89.590 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 5 (n= 8) | -179.18 | Standard Deviation 101.260 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 6 (n= 9) | -183.41 | Standard Deviation 111.313 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 8 (n= 9) | -176.72 | Standard Deviation 118.441 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 10 (n= 9) | -151.19 | Standard Deviation 78.164 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 12 (n= 9) | -109.40 | Standard Deviation 74.108 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 13 (n= 2) | -170.15 | Standard Deviation 105.288 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 14 (n= 9) | -104.16 | Standard Deviation 78.954 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 15 (n= 2) | -186.15 | Standard Deviation 119.147 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 16 (n= 9) | -97.29 | Standard Deviation 179.016 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 17 (n= 2) | -174.20 | Standard Deviation 103.803 | mg/dL |
| Absolute Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline (Week 0) Over Time in the Main Study Period | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | Change at Week 18 (n= 7) | -62.11 | Standard Deviation 167.004 | mg/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02265952/results